The FDA looks for conclusive evidence that these drugs are both effective and safe at treating obesity in people, with or without diabetes

CrossRef Childhood Underweight and Adulthood Obesity Associated With Increased Risk of MASLD and Cirrhosis: A Prospective Cohort Study of 375,125 Adults Jiadong Zeng, Jian Liang, Hao Zhang, Hanming Wang, zheyang Lin, Wenzhe Zhang, Haobin Zhang, Xudong Deng, Jiahui Lin, Minqi Liu, Minwen Chen, Yue Qiu, Zhen Zhang, Zhaohua Zhu, Yi Zeng Hepatology Research .2026;[Epub] CrossRef Dietary folate intake and metabolic dysfunction-associated steatotic liver disease: a prospective cohort study Qingchun Li, Xinyu Zhang, Fengyuan Zhao, Dongfeng Zhang, Weijing Wang, Zhongyang Zhang, Feng Yang Nutrition & Metabolism .2026;[Epub] CrossRef Comorbid type 2 diabetes and cardiovascular disease drive higher healthcare costs in MASLD/MASH: a retrospective Swedish cohort study Helena Skrder, Mattias Ekstedt, Stergios Kechagias, Riku Ota, Ying Shang, Fotis Tefos, Emilie Toresson Grip, Johan Vessby, Hannes Hagstrm Scandinavian Journal of Gastroenterology .2026

And it is exactly the kind of practical detail that separates researchers who get consistent results from those who wonder why their protocol feels different every week
Rheumatoid arthritis This is where the strongest clinical evidence exists right now
Clinicians assess sleep quality, stress levels, and activity patterns during monthly visits to identify modifiable barriers to your weight loss